New battlefields for costimulation
Open Access
- 10 April 2006
- journal article
- editorial
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 203 (4) , 817-820
- https://doi.org/10.1084/jem.20060219
Abstract
Costimulation regulates the activation of naive T cells as they first encounter antigens in the secondary lymphoid organs. But recently characterized costimulatory molecules of the B7 family appear to have roles beyond initial T cell activation. New evidence shows that negative costimulators expressed by tumors and normal tissues afford local protection from T cell–mediated attack.Keywords
This publication has 27 references indexed in Scilit:
- Tissue expression of PD-L1 mediates peripheral T cell toleranceThe Journal of Experimental Medicine, 2006
- B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinomaThe Journal of Experimental Medicine, 2006
- Inflammation-associated immune suppression in cancer: The roles played by cytokines, chemokines and additional mediatorsSeminars in Cancer Biology, 2006
- Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and MetastasisPublished by Elsevier ,2006
- Distinct Role of Macrophages in Different Tumor MicroenvironmentsCancer Research, 2006
- A critical role for the programmed death ligand 1 in fetomaternal toleranceThe Journal of Experimental Medicine, 2005
- THE B7 FAMILY REVISITEDAnnual Review of Immunology, 2005
- The B7 family member B7-H3 preferentially down-regulates T helper type 1–mediated immune responsesNature Immunology, 2003
- BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1Nature Immunology, 2003
- A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humansNature Genetics, 2002